CVKD stock results show that Cadrenal Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
Articles
SYRE Stock Earnings: Spyre Therapeutics Beats EPS for Q2 2024
SYRE stock results show that Spyre Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q2 2024
TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
PLRX Stock Earnings: Pliant Therapeutics Misses EPS for Q2 2024
PLRX stock results show that Pliant Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
GRP-U Stock Earnings: Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc. Reported Results for Q2 2024
Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc. just reported results for the second quarter of 2024. More
